Literature DB >> 20056716

Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactions.

Hans J Kueng1, Calin Manta, Daniela Haiderer, Victoria M Leb, Klaus G Schmetterer, Alina Neunkirchner, Ruth A Byrne, Clemens Scheinecker, Peter Steinberger, Brian Seed, Winfried F Pickl.   

Abstract

We describe for the first time fluorescent virus-like particles decorated with biologically active mono- and multisubunit immune receptors of choice and the basic application of such fluorosomes (FSs) to visualize and target immune receptor-ligand interactions. For that purpose, human embryonic kidney (HEK)-293 cells were stably transfected with Moloney murine leukemia virus (MoMLV) matrix protein (MA) GFP fusion constructs. To produce FSs, interleukins (ILs), IL-receptors (IL-Rs), and costimulatory molecules were fused to the glycosyl phosphatidyl inositol anchor acceptor sequence of CD16b and coexpressed along with MoMLV group-specific antigen-polymerase (gag-pol) in MA::GFP(+) HEK-293 cells. We show that IL-2 decorated but not control-decorated FSs specifically identify normal and malignant IL-2 receptor-positive (IL-2R(+)) lymphocytes by flow cytometry. In addition to cytokines and costimulatory molecules, FSs were also successfully decorated with the heterotrimeric IL-2Rs, allowing identification of IL-2(+) target cells. Specificity of binding was proven by complete inhibition with nonlabeled, soluble ligands. Moreover, IL-2R FSs efficiently neutralized soluble IL-2 and thus induced unresponsiveness of T cells receiving full activation stimuli via T-cell antigen receptor and CD28. FSs are technically simple, multivalent tools for assessing and blocking mono- and multisubunit immune receptor-ligand interactions with natural constituents in a plasma membrane context.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056716      PMCID: PMC2879947          DOI: 10.1096/fj.09-137281

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  44 in total

1.  T-cell and mast cell lines respond to B-cell stimulatory factor 1.

Authors:  T R Mosmann; M W Bond; R L Coffman; J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation.

Authors:  R J Armitage; J C Cawley
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

3.  The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein.

Authors:  D Simmons; B Seed
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

4.  Induction of B cell differentiation by T cell factors. I. Stimulation of IgM secretion by products of a T cell hybridoma and a T cell line.

Authors:  E Puré; P C Isakson; K Takatsu; T Hamaoka; S L Swain; R W Dutton; G Dennert; J W Uhr; E S Vitetta
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

Review 5.  T cell replacing factors in the B cell response to antigen.

Authors:  S L Swain; G D Wetzel; P Soubiran; R W Dutton
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

6.  The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes.

Authors:  T A Waldmann
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

7.  Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.

Authors:  R J Robb; W C Greene; C M Rusk
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

8.  Detection of low and high affinity binding sites with fluoresceinated human recombinant interleukin-2.

Authors:  A Harel-Bellan; Z Mishal; J Willette-Brown; W L Farrar
Journal:  J Immunol Methods       Date:  1989-04-21       Impact factor: 2.303

9.  Modulation of allergen-specific T-lymphocyte function by virus-like particles decorated with HLA class II molecules.

Authors:  Victoria M Leb; Beatrice Jahn-Schmid; Hans J Kueng; Klaus G Schmetterer; Daniela Haiderer; Alina Neunkirchner; Gottfried F Fischer; Arnulf Hartl; Josef Thalhamer; Peter Steinberger; Barbara Bohle; Brian Seed; Winfried F Pickl
Journal:  J Allergy Clin Immunol       Date:  2009-06-04       Impact factor: 10.793

10.  Continuous proliferation of murine antigen-specific helper T lymphocytes in culture.

Authors:  J Watson
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

View more
  9 in total

1.  T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells.

Authors:  Judith Leitner; Werner Kuschei; Katharina Grabmeier-Pfistershammer; Ramona Woitek; Ernst Kriehuber; Otto Majdic; Gerhard Zlabinger; Winfried F Pickl; Peter Steinberger
Journal:  J Immunol Methods       Date:  2010-09-19       Impact factor: 2.303

Review 2.  Gammaretroviral vectors: biology, technology and application.

Authors:  Tobias Maetzig; Melanie Galla; Christopher Baum; Axel Schambach
Journal:  Viruses       Date:  2011-06-03       Impact factor: 5.048

3.  CD8+ T Cell Fate and Function Influenced by Antigen-Specific Virus-Like Nanoparticles Co-Expressing Membrane Tethered IL-2.

Authors:  Daniela Wojta-Stremayr; Alina Neunkirchner; Bharani Srinivasan; Doris Trapin; Klaus G Schmetterer; Winfried F Pickl
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

Review 4.  Fluorosomes: fluorescent virus-like nanoparticles that represent a convenient tool to visualize receptor-ligand interactions.

Authors:  Daniela Wojta-Stremayr; Winfried F Pickl
Journal:  Sensors (Basel)       Date:  2013-07-08       Impact factor: 3.576

5.  Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice.

Authors:  Alina Neunkirchner; Bernhard Kratzer; Cordula Köhler; Ursula Smole; Lukas F Mager; Klaus G Schmetterer; Doris Trapin; Victoria Leb-Reichl; Edward Rosloniec; Ronald Naumann; Lukas Kenner; Beatrice Jahn-Schmid; Barbara Bohle; Rudolf Valenta; Winfried F Pickl
Journal:  EBioMedicine       Date:  2018-04-05       Impact factor: 8.143

Review 6.  Biomedical applications of glycosylphosphatidylinositol-anchored proteins.

Authors:  Susanne Heider; John A Dangerfield; Christoph Metzner
Journal:  J Lipid Res       Date:  2016-08-19       Impact factor: 5.922

Review 7.  Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?

Authors:  Inna Tulaeva; Bernhard Kratzer; Raffaela Campana; Mirela Curin; Marianne van Hage; Antonina Karsonova; Ksenja Riabova; Alexander Karaulov; Musa Khaitov; Winfried F Pickl; Rudolf Valenta
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

8.  Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model.

Authors:  Bernhard Kratzer; Cordula Köhler; Sandra Hofer; Ursula Smole; Doris Trapin; Jagoba Iturri; Dietmar Pum; Philip Kienzl; Adelheid Elbe-Bürger; Pia Gattinger; Irene Mittermann; Birgit Linhart; Gabriele Gadermaier; Beatrice Jahn-Schmid; Alina Neunkirchner; Rudolf Valenta; Winfried F Pickl
Journal:  Allergy       Date:  2018-11-05       Impact factor: 13.146

Review 9.  Past, present, and future of allergen immunotherapy vaccines.

Authors:  Yulia Dorofeeva; Igor Shilovskiy; Inna Tulaeva; Margarete Focke-Tejkl; Sabine Flicker; Dmitriy Kudlay; Musa Khaitov; Antonina Karsonova; Ksenja Riabova; Alexander Karaulov; Roman Khanferyan; Winfried F Pickl; Thomas Wekerle; Rudolf Valenta
Journal:  Allergy       Date:  2020-04-29       Impact factor: 13.146

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.